Biomarker analysis of cetuximab plus oxaliplatin/leucovorin/5-fluorouracil in first-line metastatic gastric and oesophago-gastric junction cancer: results from a phase II trial of the…

Overview of attention for article published in BMC Cancer, December 2011

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (65th percentile)

Mentioned by

patent: 2 patents

Citations

dimensions_citation: 62 Dimensions

Readers on

mendeley: 50 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 2 patents that reference this research output.

PROGNOSTIC AND TREATMENT RESPONSE PREDICTIVE METHOD

Application WO-2019074445-A1

World Intellectual Property Organisation (WIPO)

INHIBITORS OF PHOSPHATIDIC ACID PHOSPHOHYDROLASE (PAP), INCLUDING D-PROPRANOLOL AND…

Application WO-2012135970-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.